Lost Password? No account yet? Register

Advertisement

New Media Advertisement
Environmental biotech products to reach $261.3 million by 2013 in US PDF Print E-mail
User Rating: / 0
PoorBest 

Advances technological has shaped and nature has been transformed by science and offers us unlimited potential in using environmental biotechnology - the US market for environmental biotechnology products for waste treatment is expected to be worth $180.2 million in 2008.

The US market for environmental biotechnology products for waste treatment is expected to be worth $180.2 million in 2008. This is expected to increase to $261.3 million by 2013, a compound average annual growth rate (CAGR) of 7.7%, according to a new technical market research report, Environmental Markets For Biotechnology from BCC Research.

The report noted that the market is broken down into applications of microbial blends, nutrients, enzymes and microbes. Of these, microbial blends have the largest share of the environmental biotechnology market. Expected to be worth $89.2 million in 2008, this segment will increase to $130.6 million in 2013 for a CAGR of 7.9%. Microbial blends will continue to hold the highest sales as the most versatile product choice for a wide variety of treatments.

Nutrients, the second largest segment, will increase at a slightly faster pace with sales in 2008 of $43.6 million and $66.2 million in 2013, representing a CAGR of 8.7%. Enzymes will grow at a slower pace from $32.0 million in 2008 to $40.4 million in 2013, for a CAGR of 4.8%, due to relatively limited potential compared to the products forecasted, and limited effectiveness. Microbes are expected to grow from $15.5 million in 2008 to $24.1 million in 2013, for the highest CAGR of 9.3%. Microbes are expected to increase in relation to growing biofuel production from anaerobic waste treatment methods. Biotechnology also has a promising future in helping us meet our energy demands by converting waste to biofuels.

 
< Prev   Next >

Retailing

Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only…     Readmore

Image

Outsourcing

The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some…     Readmore

Image

Homeopathy

The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G     Readmore

FDA

Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics,  has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2…     Readmore

Biotechnology

Attractive incentives and tax soaps offered by the Malaysian government for the biotech and research based companies is luring some major Indian pharmaceutical players to set up units in…     Readmore

Nanotechnology

The UK Royal Commission has issued a report on the spread of nanomaterials, stating that “urgent action [is] needed on testing and regulation”. In its report the Commission found…     Readmore

Packaging

Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and…     Readmore